nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—Diplopia—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Dexmethylphenidate—Asthma—Methotrexate—muscle cancer	0.00164	0.00164	CcSEcCtD
Dexmethylphenidate—Chest pain—Etoposide—muscle cancer	0.00163	0.00163	CcSEcCtD
Dexmethylphenidate—Migraine—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Dexmethylphenidate—Affect lability—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00162	0.00162	CcSEcCtD
Dexmethylphenidate—Pancreatitis—Methotrexate—muscle cancer	0.00161	0.00161	CcSEcCtD
Dexmethylphenidate—Discomfort—Etoposide—muscle cancer	0.00161	0.00161	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Dactinomycin—muscle cancer	0.00159	0.00159	CcSEcCtD
Dexmethylphenidate—Abdominal discomfort—Methotrexate—muscle cancer	0.00157	0.00157	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Vincristine—muscle cancer	0.00157	0.00157	CcSEcCtD
Dexmethylphenidate—Confusional state—Etoposide—muscle cancer	0.00157	0.00157	CcSEcCtD
Dexmethylphenidate—Cardiac arrest—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Dexmethylphenidate—Pancytopenia—Methotrexate—muscle cancer	0.00156	0.00156	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Etoposide—muscle cancer	0.00156	0.00156	CcSEcCtD
Dexmethylphenidate—Mood swings—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Dexmethylphenidate—Infection—Etoposide—muscle cancer	0.00155	0.00155	CcSEcCtD
Dexmethylphenidate—Asthenia—Dactinomycin—muscle cancer	0.00155	0.00155	CcSEcCtD
Dexmethylphenidate—Dehydration—Doxorubicin—muscle cancer	0.00153	0.00153	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Etoposide—muscle cancer	0.00153	0.00153	CcSEcCtD
Dexmethylphenidate—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00153	0.00153	CcSEcCtD
Dexmethylphenidate—Tachycardia—Etoposide—muscle cancer	0.00152	0.00152	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Vincristine—muscle cancer	0.00152	0.00152	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Vincristine—muscle cancer	0.00152	0.00152	CcSEcCtD
Dexmethylphenidate—Liver function test abnormal—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Dexmethylphenidate—Skin disorder—Etoposide—muscle cancer	0.00151	0.00151	CcSEcCtD
Dexmethylphenidate—Erectile dysfunction—Methotrexate—muscle cancer	0.00151	0.00151	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Etoposide—muscle cancer	0.00151	0.00151	CcSEcCtD
Dexmethylphenidate—Abdominal pain upper—Doxorubicin—muscle cancer	0.0015	0.0015	CcSEcCtD
Dexmethylphenidate—Photosensitivity reaction—Methotrexate—muscle cancer	0.0015	0.0015	CcSEcCtD
Dexmethylphenidate—Breast disorder—Doxorubicin—muscle cancer	0.00149	0.00149	CcSEcCtD
Dexmethylphenidate—Anorexia—Etoposide—muscle cancer	0.00149	0.00149	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Dactinomycin—muscle cancer	0.00147	0.00147	CcSEcCtD
Dexmethylphenidate—Pneumonia—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Dexmethylphenidate—Nasopharyngitis—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Dexmethylphenidate—Infestation NOS—Methotrexate—muscle cancer	0.00146	0.00146	CcSEcCtD
Dexmethylphenidate—Infestation—Methotrexate—muscle cancer	0.00146	0.00146	CcSEcCtD
Dexmethylphenidate—Drowsiness—Methotrexate—muscle cancer	0.00146	0.00146	CcSEcCtD
Dexmethylphenidate—Depression—Methotrexate—muscle cancer	0.00146	0.00146	CcSEcCtD
Dexmethylphenidate—Gastritis—Doxorubicin—muscle cancer	0.00146	0.00146	CcSEcCtD
Dexmethylphenidate—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00145	0.00145	CcSEcCtD
Dexmethylphenidate—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00145	0.00145	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Dexmethylphenidate—Influenza—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Dexmethylphenidate—Asthma—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Vincristine—muscle cancer	0.00142	0.00142	CcSEcCtD
Dexmethylphenidate—Sweating—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Etoposide—muscle cancer	0.0014	0.0014	CcSEcCtD
Dexmethylphenidate—Haematuria—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Dexmethylphenidate—Pancreatitis—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Etoposide—muscle cancer	0.00139	0.00139	CcSEcCtD
Dexmethylphenidate—Somnolence—Etoposide—muscle cancer	0.00139	0.00139	CcSEcCtD
Dexmethylphenidate—Angina pectoris—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Dexmethylphenidate—Epistaxis—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Dexmethylphenidate—Asthenia—Vincristine—muscle cancer	0.00138	0.00138	CcSEcCtD
Dexmethylphenidate—Vomiting—Dactinomycin—muscle cancer	0.00137	0.00137	CcSEcCtD
Dexmethylphenidate—Bronchitis—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Dexmethylphenidate—Rash—Dactinomycin—muscle cancer	0.00136	0.00136	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Etoposide—muscle cancer	0.00136	0.00136	CcSEcCtD
Dexmethylphenidate—Pancytopenia—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Etoposide—muscle cancer	0.00135	0.00135	CcSEcCtD
Dexmethylphenidate—Fatigue—Etoposide—muscle cancer	0.00134	0.00134	CcSEcCtD
Dexmethylphenidate—Pain—Etoposide—muscle cancer	0.00133	0.00133	CcSEcCtD
Dexmethylphenidate—Constipation—Etoposide—muscle cancer	0.00133	0.00133	CcSEcCtD
Dexmethylphenidate—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Methotrexate—muscle cancer	0.00132	0.00132	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Vincristine—muscle cancer	0.00132	0.00132	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Methotrexate—muscle cancer	0.00131	0.00131	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Methotrexate—muscle cancer	0.0013	0.0013	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Methotrexate—muscle cancer	0.0013	0.0013	CcSEcCtD
Dexmethylphenidate—Photosensitivity reaction—Doxorubicin—muscle cancer	0.0013	0.0013	CcSEcCtD
Dexmethylphenidate—Weight increased—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Methotrexate—muscle cancer	0.00129	0.00129	CcSEcCtD
Dexmethylphenidate—Weight decreased—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Etoposide—muscle cancer	0.00128	0.00128	CcSEcCtD
Dexmethylphenidate—Nausea—Dactinomycin—muscle cancer	0.00128	0.00128	CcSEcCtD
Dexmethylphenidate—Pneumonia—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Etoposide—muscle cancer	0.00127	0.00127	CcSEcCtD
Dexmethylphenidate—Dizziness—Vincristine—muscle cancer	0.00127	0.00127	CcSEcCtD
Dexmethylphenidate—Drowsiness—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Dexmethylphenidate—Infestation NOS—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Dexmethylphenidate—Infestation—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Dexmethylphenidate—Visual impairment—Methotrexate—muscle cancer	0.00127	0.00127	CcSEcCtD
Dexmethylphenidate—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00126	0.00126	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Dexmethylphenidate—Urticaria—Etoposide—muscle cancer	0.00124	0.00124	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Etoposide—muscle cancer	0.00123	0.00123	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Etoposide—muscle cancer	0.00123	0.00123	CcSEcCtD
Dexmethylphenidate—Conjunctivitis—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Dexmethylphenidate—Eye disorder—Methotrexate—muscle cancer	0.00123	0.00123	CcSEcCtD
Dexmethylphenidate—Vomiting—Vincristine—muscle cancer	0.00122	0.00122	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Methotrexate—muscle cancer	0.00122	0.00122	CcSEcCtD
Dexmethylphenidate—Sweating—Doxorubicin—muscle cancer	0.00122	0.00122	CcSEcCtD
Dexmethylphenidate—Rash—Vincristine—muscle cancer	0.00121	0.00121	CcSEcCtD
Dexmethylphenidate—Dermatitis—Vincristine—muscle cancer	0.00121	0.00121	CcSEcCtD
Dexmethylphenidate—Haematuria—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Dexmethylphenidate—Headache—Vincristine—muscle cancer	0.00121	0.00121	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Doxorubicin—muscle cancer	0.0012	0.0012	CcSEcCtD
Dexmethylphenidate—Epistaxis—Doxorubicin—muscle cancer	0.0012	0.0012	CcSEcCtD
Dexmethylphenidate—Angiopathy—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Dexmethylphenidate—Sinusitis—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Methotrexate—muscle cancer	0.00118	0.00118	CcSEcCtD
Dexmethylphenidate—Chills—Methotrexate—muscle cancer	0.00118	0.00118	CcSEcCtD
Dexmethylphenidate—Alopecia—Methotrexate—muscle cancer	0.00116	0.00116	CcSEcCtD
Dexmethylphenidate—Bradycardia—Doxorubicin—muscle cancer	0.00116	0.00116	CcSEcCtD
Dexmethylphenidate—Mental disorder—Methotrexate—muscle cancer	0.00115	0.00115	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Etoposide—muscle cancer	0.00115	0.00115	CcSEcCtD
Dexmethylphenidate—Erythema—Methotrexate—muscle cancer	0.00114	0.00114	CcSEcCtD
Dexmethylphenidate—Malnutrition—Methotrexate—muscle cancer	0.00114	0.00114	CcSEcCtD
Dexmethylphenidate—Haemoglobin—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Dexmethylphenidate—Nausea—Vincristine—muscle cancer	0.00114	0.00114	CcSEcCtD
Dexmethylphenidate—Rhinitis—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Dexmethylphenidate—Haemorrhage—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Doxorubicin—muscle cancer	0.00113	0.00113	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Dexmethylphenidate—Asthenia—Etoposide—muscle cancer	0.00112	0.00112	CcSEcCtD
Dexmethylphenidate—Connective tissue disorder—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Dexmethylphenidate—Back pain—Methotrexate—muscle cancer	0.00111	0.00111	CcSEcCtD
Dexmethylphenidate—Pruritus—Etoposide—muscle cancer	0.0011	0.0011	CcSEcCtD
Dexmethylphenidate—Visual impairment—Doxorubicin—muscle cancer	0.0011	0.0011	CcSEcCtD
Dexmethylphenidate—Vision blurred—Methotrexate—muscle cancer	0.00108	0.00108	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Etoposide—muscle cancer	0.00107	0.00107	CcSEcCtD
Dexmethylphenidate—Eye disorder—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Methotrexate—muscle cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Anaemia—Methotrexate—muscle cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Flushing—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Cardiac disorder—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Dexmethylphenidate—Angiopathy—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Dexmethylphenidate—Malaise—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Dexmethylphenidate—Dizziness—Etoposide—muscle cancer	0.00103	0.00103	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Dexmethylphenidate—Vertigo—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Dexmethylphenidate—Leukopenia—Methotrexate—muscle cancer	0.00102	0.00102	CcSEcCtD
Dexmethylphenidate—Chills—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
Dexmethylphenidate—Alopecia—Doxorubicin—muscle cancer	0.00101	0.00101	CcSEcCtD
Dexmethylphenidate—Cough—Methotrexate—muscle cancer	0.000999	0.000999	CcSEcCtD
Dexmethylphenidate—Mental disorder—Doxorubicin—muscle cancer	0.000997	0.000997	CcSEcCtD
Dexmethylphenidate—Convulsion—Methotrexate—muscle cancer	0.000991	0.000991	CcSEcCtD
Dexmethylphenidate—Vomiting—Etoposide—muscle cancer	0.000991	0.000991	CcSEcCtD
Dexmethylphenidate—Erythema—Doxorubicin—muscle cancer	0.000991	0.000991	CcSEcCtD
Dexmethylphenidate—Malnutrition—Doxorubicin—muscle cancer	0.000991	0.000991	CcSEcCtD
Dexmethylphenidate—Rash—Etoposide—muscle cancer	0.000983	0.000983	CcSEcCtD
Dexmethylphenidate—Dermatitis—Etoposide—muscle cancer	0.000982	0.000982	CcSEcCtD
Dexmethylphenidate—Headache—Etoposide—muscle cancer	0.000977	0.000977	CcSEcCtD
Dexmethylphenidate—Chest pain—Methotrexate—muscle cancer	0.000974	0.000974	CcSEcCtD
Dexmethylphenidate—Arthralgia—Methotrexate—muscle cancer	0.000974	0.000974	CcSEcCtD
Dexmethylphenidate—Myalgia—Methotrexate—muscle cancer	0.000974	0.000974	CcSEcCtD
Dexmethylphenidate—Tension—Doxorubicin—muscle cancer	0.000972	0.000972	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000967	0.000967	CcSEcCtD
Dexmethylphenidate—Discomfort—Methotrexate—muscle cancer	0.000963	0.000963	CcSEcCtD
Dexmethylphenidate—Nervousness—Doxorubicin—muscle cancer	0.000962	0.000962	CcSEcCtD
Dexmethylphenidate—Back pain—Doxorubicin—muscle cancer	0.000958	0.000958	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Doxorubicin—muscle cancer	0.000953	0.000953	CcSEcCtD
Dexmethylphenidate—Confusional state—Methotrexate—muscle cancer	0.000942	0.000942	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Methotrexate—muscle cancer	0.000934	0.000934	CcSEcCtD
Dexmethylphenidate—Vision blurred—Doxorubicin—muscle cancer	0.000934	0.000934	CcSEcCtD
Dexmethylphenidate—Infection—Methotrexate—muscle cancer	0.000928	0.000928	CcSEcCtD
Dexmethylphenidate—Nausea—Etoposide—muscle cancer	0.000926	0.000926	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Doxorubicin—muscle cancer	0.000919	0.000919	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Methotrexate—muscle cancer	0.000916	0.000916	CcSEcCtD
Dexmethylphenidate—Anaemia—Doxorubicin—muscle cancer	0.000916	0.000916	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Methotrexate—muscle cancer	0.000914	0.000914	CcSEcCtD
Dexmethylphenidate—Agitation—Doxorubicin—muscle cancer	0.000911	0.000911	CcSEcCtD
Dexmethylphenidate—Skin disorder—Methotrexate—muscle cancer	0.000907	0.000907	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Methotrexate—muscle cancer	0.000903	0.000903	CcSEcCtD
Dexmethylphenidate—Malaise—Doxorubicin—muscle cancer	0.000894	0.000894	CcSEcCtD
Dexmethylphenidate—Vertigo—Doxorubicin—muscle cancer	0.00089	0.00089	CcSEcCtD
Dexmethylphenidate—Anorexia—Methotrexate—muscle cancer	0.00089	0.00089	CcSEcCtD
Dexmethylphenidate—Syncope—Doxorubicin—muscle cancer	0.000889	0.000889	CcSEcCtD
Dexmethylphenidate—Leukopenia—Doxorubicin—muscle cancer	0.000887	0.000887	CcSEcCtD
Dexmethylphenidate—Palpitations—Doxorubicin—muscle cancer	0.000876	0.000876	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Doxorubicin—muscle cancer	0.000871	0.000871	CcSEcCtD
Dexmethylphenidate—Cough—Doxorubicin—muscle cancer	0.000865	0.000865	CcSEcCtD
Dexmethylphenidate—Convulsion—Doxorubicin—muscle cancer	0.000858	0.000858	CcSEcCtD
Dexmethylphenidate—Hypertension—Doxorubicin—muscle cancer	0.000855	0.000855	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000851	0.000851	CcSEcCtD
Dexmethylphenidate—Insomnia—Methotrexate—muscle cancer	0.000845	0.000845	CcSEcCtD
Dexmethylphenidate—Chest pain—Doxorubicin—muscle cancer	0.000844	0.000844	CcSEcCtD
Dexmethylphenidate—Myalgia—Doxorubicin—muscle cancer	0.000844	0.000844	CcSEcCtD
Dexmethylphenidate—Arthralgia—Doxorubicin—muscle cancer	0.000844	0.000844	CcSEcCtD
Dexmethylphenidate—Anxiety—Doxorubicin—muscle cancer	0.000841	0.000841	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Methotrexate—muscle cancer	0.000839	0.000839	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000838	0.000838	CcSEcCtD
Dexmethylphenidate—Discomfort—Doxorubicin—muscle cancer	0.000833	0.000833	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Methotrexate—muscle cancer	0.000833	0.000833	CcSEcCtD
Dexmethylphenidate—Somnolence—Methotrexate—muscle cancer	0.00083	0.00083	CcSEcCtD
Dexmethylphenidate—Dry mouth—Doxorubicin—muscle cancer	0.000825	0.000825	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Methotrexate—muscle cancer	0.000822	0.000822	CcSEcCtD
Dexmethylphenidate—Confusional state—Doxorubicin—muscle cancer	0.000815	0.000815	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Methotrexate—muscle cancer	0.000812	0.000812	CcSEcCtD
Dexmethylphenidate—Oedema—Doxorubicin—muscle cancer	0.000809	0.000809	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Doxorubicin—muscle cancer	0.000809	0.000809	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000806	0.000806	CcSEcCtD
Dexmethylphenidate—Fatigue—Methotrexate—muscle cancer	0.000805	0.000805	CcSEcCtD
Dexmethylphenidate—Infection—Doxorubicin—muscle cancer	0.000803	0.000803	CcSEcCtD
Dexmethylphenidate—Pain—Methotrexate—muscle cancer	0.000799	0.000799	CcSEcCtD
Dexmethylphenidate—Shock—Doxorubicin—muscle cancer	0.000796	0.000796	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Doxorubicin—muscle cancer	0.000793	0.000793	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Doxorubicin—muscle cancer	0.000792	0.000792	CcSEcCtD
Dexmethylphenidate—Tachycardia—Doxorubicin—muscle cancer	0.000789	0.000789	CcSEcCtD
Dexmethylphenidate—Skin disorder—Doxorubicin—muscle cancer	0.000785	0.000785	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Doxorubicin—muscle cancer	0.000782	0.000782	CcSEcCtD
Dexmethylphenidate—Anorexia—Doxorubicin—muscle cancer	0.000771	0.000771	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Methotrexate—muscle cancer	0.00077	0.00077	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Methotrexate—muscle cancer	0.000764	0.000764	CcSEcCtD
Dexmethylphenidate—Urticaria—Methotrexate—muscle cancer	0.000742	0.000742	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Methotrexate—muscle cancer	0.000738	0.000738	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Methotrexate—muscle cancer	0.000738	0.000738	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000737	0.000737	CcSEcCtD
Dexmethylphenidate—Insomnia—Doxorubicin—muscle cancer	0.000731	0.000731	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Doxorubicin—muscle cancer	0.000726	0.000726	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Doxorubicin—muscle cancer	0.000721	0.000721	CcSEcCtD
Dexmethylphenidate—Somnolence—Doxorubicin—muscle cancer	0.000719	0.000719	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Doxorubicin—muscle cancer	0.000712	0.000712	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Doxorubicin—muscle cancer	0.000703	0.000703	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000698	0.000698	CcSEcCtD
Dexmethylphenidate—Fatigue—Doxorubicin—muscle cancer	0.000697	0.000697	CcSEcCtD
Dexmethylphenidate—Constipation—Doxorubicin—muscle cancer	0.000692	0.000692	CcSEcCtD
Dexmethylphenidate—Pain—Doxorubicin—muscle cancer	0.000692	0.000692	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Methotrexate—muscle cancer	0.000688	0.000688	CcSEcCtD
Dexmethylphenidate—Asthenia—Methotrexate—muscle cancer	0.00067	0.00067	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Doxorubicin—muscle cancer	0.000666	0.000666	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000661	0.000661	CcSEcCtD
Dexmethylphenidate—Pruritus—Methotrexate—muscle cancer	0.000661	0.000661	CcSEcCtD
Dexmethylphenidate—Urticaria—Doxorubicin—muscle cancer	0.000642	0.000642	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Doxorubicin—muscle cancer	0.000639	0.000639	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Doxorubicin—muscle cancer	0.000639	0.000639	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Methotrexate—muscle cancer	0.000639	0.000639	CcSEcCtD
Dexmethylphenidate—Dizziness—Methotrexate—muscle cancer	0.000618	0.000618	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Doxorubicin—muscle cancer	0.000596	0.000596	CcSEcCtD
Dexmethylphenidate—Vomiting—Methotrexate—muscle cancer	0.000594	0.000594	CcSEcCtD
Dexmethylphenidate—Rash—Methotrexate—muscle cancer	0.000589	0.000589	CcSEcCtD
Dexmethylphenidate—Dermatitis—Methotrexate—muscle cancer	0.000588	0.000588	CcSEcCtD
Dexmethylphenidate—Headache—Methotrexate—muscle cancer	0.000585	0.000585	CcSEcCtD
Dexmethylphenidate—Asthenia—Doxorubicin—muscle cancer	0.00058	0.00058	CcSEcCtD
Dexmethylphenidate—Pruritus—Doxorubicin—muscle cancer	0.000572	0.000572	CcSEcCtD
Dexmethylphenidate—Nausea—Methotrexate—muscle cancer	0.000555	0.000555	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Doxorubicin—muscle cancer	0.000553	0.000553	CcSEcCtD
Dexmethylphenidate—Dizziness—Doxorubicin—muscle cancer	0.000535	0.000535	CcSEcCtD
Dexmethylphenidate—Vomiting—Doxorubicin—muscle cancer	0.000514	0.000514	CcSEcCtD
Dexmethylphenidate—Rash—Doxorubicin—muscle cancer	0.00051	0.00051	CcSEcCtD
Dexmethylphenidate—Dermatitis—Doxorubicin—muscle cancer	0.000509	0.000509	CcSEcCtD
Dexmethylphenidate—Headache—Doxorubicin—muscle cancer	0.000507	0.000507	CcSEcCtD
Dexmethylphenidate—Nausea—Doxorubicin—muscle cancer	0.00048	0.00048	CcSEcCtD
